“Barely slept last night after we announced funding for a £3.2m DNA study partnership that I Chair. Seven years+ of advocacy and lobbying final paid off.” Sonya Chowdhury, CEO of Action for ME – a leader in the effort When the Brits do it, sometimes...
EpicGenetics – a biotech firm in Los Angeles – is attempting an FM trifecta: produce a blood and genomic test and provide a treatment. EpicGenetics is trying to make a big splash in fibromyalgia. A Los Angeles biotech firm, they focused on producing...
Solve ME funds seven pilot studies on chronic fatigue syndrome (ME/CFS) in its 2019 Ramsay Awards The great thing about Solve ME’s Ramsay awards is their sheer breadth. Particularly with the 2019 awards, the Ramsays are dropping seeds across the biological...
A recent Klimas/Broderick study had a lot of interesting things in it: the gender divide, and the illumination of possibly key immune and metabolic factors, but the most intriguing thing about the study was its potential precision. The study possibly identified...
If there was ever a “prodigal virus” in ME/CFS, it would be the Epstein-barr virus (EBV). Since the first EBV ME/CFS study in 1984, dozens of studies have examined the role the virus may play in this diseases, and tens of thousands have studied its...
Dr. Camille Birch has a PhD in biomedical engineering and hails from the Hudson Alpha Institute for Biotechnology at Huntsville, Alabama. Hudson Alpha, only 11 years old, is one of those new biotechnology efforts that’s using sophisticated bioinformatics to...
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.